Keywords: vical, trials, allovectin-7, early-stage, cancer, patients, naked

Vical trials Allovectin-7 in early-stage cancer patients

Article | 15 February 2001

Print This

US naked DNA vaccine specialist Vical has started a Phase II trial ofits investigational Allovectin-7 product in patients scheduled for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in